Article info
PDFOriginal research
Importance of systematic deliberation and stakeholder presence: a national study of clinical ethics committees
Citation
Importance of systematic deliberation and stakeholder presence: a national study of clinical ethics committees
Publication history
- Received October 5, 2018
- Revised March 29, 2019
- Accepted August 25, 2019
- First published September 5, 2019.
Online issue publication
February 07, 2020
Article Versions
- Previous version (7 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Development of clinical ethics services in the UK: a national survey
- The quality of bioethics debate: implications for clinical ethics committees
- Consultation activities of clinical ethics committees in the United Kingdom: an empirical study and wake-up call
- Training clinical ethics committee members between 1992 and 2017: systematic scoping review
- Implementing clinical ethics in German hospitals: content, didactics and evaluation of a nationwide postgraduate training programme
- Clinical ethics support services in the UK: an investigation of the current provision of ethics support to health professionals in the UK
- Evolution of hospital clinical ethics committees in Canada
- Snapshots of five clinical ethics committees in the UK
- Challenging misconceptions about clinical ethics support during COVID-19 and beyond: a legal update and future considerations
- What is the role of clinical ethics support in the era of e-medicine?